Transcranial Photobiomodulation for Executive Function in Bipolar Disorder

Part of paid clinical trials in Charlestown, Massachusetts.

Sponsor
Paolo Cassano
Study ID
NCT05408637
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Transcranial Phoobiomodulation (tPBM) — DEVICE
    Transcranial light therapy penetrates the skin and brain using light energy; this makes transcranial light therapy noninvasive. Transcranial light therapy may activate under-stimulated brain regions.

Study Details

Transcranial light therapy, or transcranial photobiomodulation (tPBM), is a treatment that stimulates the brain by applying near-infrared light to the forehead. Transcranial light therapy has been found to promote brain metabolism, which may help improve executive function in people with bipolar disorder. The research team proposes a novel approach to treating bipolar disorder by using transcranial light therapy.

Key Dates

Start date
Aug 9, 2022
Status verified
Aug 2025
Primary completion
May 14, 2024
Completion
May 14, 2024

Study Design

Enrollment
13 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Test the Effect of Transcranial Photobiomodulation (tPBM) on Cerebral Blood Flow (CBF) [ Time Frame: Day 1 of tPBM Treatment ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mass General Hospital Navy Yard Building 149CharlestownMassachusetts02129-

Find similar trials in Charlestown, MA

By condition
Bipolar disorder
By specialty
PsychiatryMental healthBehavioral health
By research site
Mass General Hospital Navy Yard Building 149· Charlestown, MA

Related Studies